We are live on ! Find out more
BIND

BIND THERAPEUTICS INC
BIND

Delisted

BIND was delisted on the 29th of July, 2016.

Back to rankings

40 hedge funds and large institutions have $37.4M invested in BIND THERAPEUTICS INC in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less funds holding

Funds holding: 43 → 40 (-3)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

36% less capital invested

Capital invested by funds: $58.4M → $37.4M (-$21M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

57% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 14

Holders
40
Holders Change
-3
Holders Change %
-6.98%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
9
Increased
6
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$2.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$642K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$434K
4
HLA
Hamilton Lane Advisors
Pennsylvania
+$360K
5
BCM
Bridgeway Capital Management
Texas
+$332K

Top Sellers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
-$3.22M
2
BI
BVF Inc
California
-$1.53M
3
Northern Trust
Northern Trust
Illinois
-$699K
4
OM
Opaleye Management
Massachusetts
-$414K
5
PP
Paloma Partners
Connecticut
-$299K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$60K -$165K -16,720 -71%
Citigroup
27
Citigroup
New York
$50K +$3.85K +390 +7%
Wells Fargo
28
Wells Fargo
California
$47K +$927 +94 +2%
U
29
UBS
Switzerland
$26K +$5.55K +563 +23%
BJ
30
BlackRock Japan
Japan
$20K -$29.8K -3,024 -57%
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$15K +$14.4K +1,461 +506%
BIM
32
BlackRock Investment Management
Delaware
$11K -$128 -13 -1%
TRCT
33
Tower Research Capital (TRC)
New York
$8K +$9.54K +968 New
Morgan Stanley
34
Morgan Stanley
New York
$6K -$8.74K -887 -56%
SFPIA
35
Stevens First Principles Investment Advisors
California
$4K – – –
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$2.78K – – –
MFS
37
MSI Financial Services
Massachusetts
$2K – – –
PNC Financial Services Group
38
PNC Financial Services Group
Pennsylvania
$2K – – –
Barclays
39
Barclays
United Kingdom
$1K +$621 +63 New
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
PI
41
Putnam Investments
Massachusetts
– -$3.22M -244,100 Closed
BI
42
BVF Inc
California
– -$1.53M -116,000 Closed
Northern Trust
43
Northern Trust
Illinois
– -$699K -53,083 Closed
PP
44
Paloma Partners
Connecticut
– -$299K -22,685 Closed
COPPSERS
45
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$199K -15,133 Closed
Deutsche Bank
46
Deutsche Bank
Germany
– -$197K -14,971 Closed
LP
47
LMR Partners
United Kingdom
– -$151K -11,452 Closed
Jane Street
48
Jane Street
New York
– -$146K -11,078 Closed
EA
49
Emerald Advisers
Pennsylvania
– -$119K -9,010 Closed
FANJ
50
Financial Architects (New Jersey)
New Jersey
– -$53K -4,000 Closed
1
2
3

BIND Hedge Fund Activity: Q3 2014 in Review

40 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in BIND THERAPEUTICS INC (BIND) for Q3 2014, worth a combined $37.4M — down 36% from $58.4M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of BIND and 9 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 6 added.

The largest buyer was Deerfield Management, opening a new position worth an estimated $2.7M. The largest seller was Putnam Investments, exiting entirely with an estimated $3.22M sold.

  • 40 institutional investors held BIND THERAPEUTICS INC (BIND) as of Q3 2014, down from 43 in Q2 2014.
  • Funds reported $37.4M of BIND THERAPEUTICS INC stock for Q3 2014, down 36% quarter-over-quarter.
  • 9 funds opened new BIND THERAPEUTICS INC positions in Q3 2014 and 12 closed out, a net change of -3 holders.
  • The largest BIND THERAPEUTICS INC buyer in Q3 2014 was Deerfield Management, an estimated $2.7M added.
  • The largest BIND THERAPEUTICS INC seller in Q3 2014 was Putnam Investments, an estimated $3.22M sold.

Based on aggregated 13F filings for Q3 2014.